Miller C L, Rebel V I, Helgason C D, Lansdorp P M, Eaves C J
Terry Fox Laboratory, British Columbia Cancer Agency, Canada.
Blood. 1997 Feb 15;89(4):1214-23.
The results of previous studies have shown that the development of hematopoiesis during fetal life can occur in the absence of Steel factor (SF) signaling. On the other hand, impairment of this mechanism can severely compromise the ability of cells from adult bone marrow to regenerate hematopoiesis on their transplantation into myeloablated recipients. This apparent paradox could result from changes during ontogeny in the responsiveness of hematopoietic stem cells to regulators that may substitute for SF as well as from differences in the availability of such factors during embryogenesis and in the myeloablated adult. To investigate these possibilities, we studied the effect of W41 and W42 mutations on the numbers, phenotype, and posttransplant self-renewal behavior of primitive hematopoietic cells present in the fetal liver (FL) of 14.5-day-old mouse embryos. In W41/ W41 FL, day-12 spleen colony-forming units and long-term culture-initiating cells appeared both quantitatively and qualitatively similar to their counterparts in the FL of +/+ embryos. W41/W41 FL also contained near normal numbers (approximately 50% of controls) of transplantable lymphomyeloid stem cells with competitive reconstituting ability in myeloablated adult +/+ recipients (as assessed for up to at least 16 weeks posttransplant). Moreover, both the original phenotype of these W41/W41 competitive repopulating units (CRUs) and their clonal posttransplant output of mature progeny were normal. Similarly, when myeloablated adult +/+ mice were cotransplanted with 5 x 10(4) +/+ FL cells and a sevenfold to 70-fold excess of W41/W41 FL CRUs, the contribution of the +/+ FL CRUs to the circulating white blood cell count present 5 weeks later was markedly reduced as compared with that of mice that received only +/+ FL cells. However, over the next 3 months, the proportion of mature white blood cells that were derived from +/+ precursors increased significantly (P < .002) in all groups (to > or = 30%), indicating that the ability to sustain hematopoiesis beyond 5 weeks is more SF-dependent than the ability to initially reconstitute both lymphoid and myeloid compartments. Cells from individual FL of W42/+ matings also showed an initial ability (at 7 to 8 weeks posttransplant) to competitively repopulate both lymphoid and myeloid compartments of myeloablated +/+ adult recipients. However, in contrast to recipients of normal or W41/W41 FL cells, the repopulation obtained with the W42 mutant stem cells was transient. Secondary transplants confirmed the inability of the W42 mutant cells to regenerate or even maintain a population of transplantable stem cells. Taken together with previous results from studies of CRUs in adult W mice, these findings support the concept of changes in the way hematopoietic stem cells at different stages of development respond to the stimulatory conditions evoked in the myeloablated recipient. In addition, they provide the first definitive evidence that SF is a limiting physiological regulator of sustained hematopoietic stem cell self-renewal in vivo.
先前的研究结果表明,胎儿期造血作用的发育可以在缺乏Steel因子(SF)信号的情况下发生。另一方面,这一机制的受损会严重损害成年骨髓细胞在移植到经清髓处理的受体后再生造血作用的能力。这种明显的矛盾可能源于个体发育过程中造血干细胞对可能替代SF的调节因子反应性的变化,以及胚胎发育期间和经清髓处理的成年个体中此类因子可用性的差异。为了研究这些可能性,我们研究了W41和W42突变对14.5日龄小鼠胚胎胎儿肝脏(FL)中原始造血细胞的数量、表型和移植后自我更新行为的影响。在W41/W41 FL中,第12天的脾集落形成单位和长期培养起始细胞在数量和质量上与其+/+胚胎FL中的对应细胞相似。W41/W41 FL还含有数量接近正常(约为对照组的50%)的可移植淋巴髓样干细胞,这些干细胞在经清髓处理的成年+/+受体中具有竞争性重建能力(移植后至少评估16周)。此外,这些W41/W41竞争性再增殖单位(CRU)的原始表型及其移植后成熟后代的克隆产量均正常。同样,当经清髓处理的成年+/+小鼠与5×10⁴个+/+ FL细胞以及7至70倍过量的W41/W41 FL CRU共同移植时,与仅接受+/+ FL细胞的小鼠相比,5周后+/+ FL CRU对循环白细胞计数的贡献明显降低。然而,在接下来的3个月中,所有组中源自+/+前体的成熟白细胞比例均显著增加(P <.002)(至≥30%),这表明维持造血作用超过5周的能力比最初重建淋巴和髓样区室的能力更依赖SF。来自W42/+交配个体FL的细胞在移植后7至8周也显示出最初竞争性重建经清髓处理的成年+/+受体的淋巴和髓样区室的能力。然而,与正常或W41/W41 FL细胞的受体不同,用W42突变干细胞获得的重建是短暂的。二次移植证实W42突变细胞无法再生甚至维持可移植干细胞群体。结合先前对成年W小鼠CRU的研究结果,这些发现支持了不同发育阶段的造血干细胞对经清髓处理的受体中诱发的刺激条件反应方式发生变化的概念。此外,它们提供了首个确凿证据,证明SF是体内持续造血干细胞自我更新的限制性生理调节因子。